Sunday, 8 November 2026
Bundibugyo vaccine trial begins, India caps cancer drug margins, Branded obesity drugs join telehealth
- 01
Tumaini trial begins testing vaccines against Bundibugyo virus
The Tumaini trial has begun to investigate vaccines against Bundibugyo virus infection in DR Congo. It aims to identify vaccines that are effective against the infection. The source says Bundibugyo virus infection has killed more than 5000 people in the country. It gives limited detail about the trial’s design, participants, vaccine candidates or timeline.
via The Lancet
- 02
India to cap trade margins on 137 cancer drugs
India’s National Pharmaceutical Pricing Authority will limit trade margins on 137 cancer drugs following a Supreme Court ruling. The measure covers life-saving medicines, but the source gives limited detail on its scope, timing or implementation.
via The Lancet
- 03
Lilly brings branded obesity drugs to Hims telehealth platform
Eli Lilly will offer its obesity drugs Zepbound and Foundayo through Hims & Hers’ telehealth platform. Eligible patients with a prescription can access the medicines at the same self-pay prices available elsewhere, with Foundayo initially priced at $149 per month and Zepbound starting at $299 per month. The agreement follows Hims’ move away from lower-cost compounded GLP-1 weight-loss drugs after a legal challenge from Novo in March. Hims has since focused on providing US consumers with access to FDA-approved weight-loss medicines and reached a similar agreement with Novo in March.
via BioPharma Dive
- 04
CMS expands Medicare revocation powers over owner conduct
The US Centers for Medicare and Medicaid Services has expanded its authority to deny or revoke Medicare enrolment when a provider’s owners or parent companies breach rules in other federal health programs or face specified licensing action. The 2027 Home Health Prospective Payment System final rule also requires home health agencies, hospices and medical equipment suppliers to re-enrol as new Medicare providers after a change in majority ownership. The CMS said failure to complete new accreditation could result in providers losing the ability to bill or enrol in Medicare, while enforcement actions will apply retrospectively from notification of noncompliance. Regulators said the changes would strengthen oversight of providers considered high risk to Medicare payment integrity and save taxpayers $82 million annually. The rule also increased home health agency payments by $415 million, or 2.4%, next year.
via Healthcare Dive
- 05
US court lifts freeze on new ACA broker registrations
A US federal judge struck down a moratorium on new broker registrations for Affordable Care Act exchanges, allowing new agents and brokers to begin training and participate in the current open-enrolment period. The Centers for Medicare and Medicaid Services imposed the freeze in September to combat alleged improper enrolments and fraud, preventing nearly 19,000 agents and brokers from registering. Two broker trade groups challenged the measure, arguing that regulators had not allowed public comment and had failed to consider the financial harm to broker organisations. The Maryland district court found the groups were likely to succeed if the litigation continued and that their members faced irreparable harm without preliminary relief. Its injunction directed the trade groups to make training available to new agents and brokers by close of business Friday.
via Healthcare Dive
- 06
Michael Clements to leave RACGP Rural Chair role
Associate Professor Michael Clements will soon leave his role as RACGP Rural Chair after reaching the maximum six-year term. The Townsville GP and practice owner, elected Chair in 2020, has combined college leadership with outreach services to remote towns near the Gulf of Carpentaria. His tenure spanned rural generalist recognition within general practice in 2025, Fellowship accreditation in 2026, the return of GP training to the RACGP and development of the Rural Generalist Anaesthesia qualification. Clements said increased attention on rural generalists should not detract from rural GPs who provide critical community care without practising obstetrics or emergency medicine.
via RACGP newsGP
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.